Deucravacitinib demonstrated superiority to placebo and Otezla in phase III
Trial will evaluate Sativex (nabiximols) for multiple sclerosis spasticity
British drugmaker confirmed review on Sunday
Updated Date: Tue, 27 Oct 2020 00:00:00 EDT
Updated Date: Tue, 27 Oct 2020 00:00:00 EDT
Amgen’s Otezla faces a hit from Bristol’s would-be rival, but safety data will tell the full story esagonowsky […]
Inspired by a parasitic worm that digs its sharp teeth into its host’s intestines, researchers have designed tiny, […]
A hybrid implant coating made from antibacterial silver and an antibiotic will protect patients from infection in the […]
Researchers at the RIKEN Center for Biosystems Dynamics Research have developed human-skin equivalent that reproduces traction-force balance in […]
Liverpool will this week become the first city in England to roll out mass testing of its population […]